Amphastar Pharma (AMPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 166,392 | 172,862 | 126,588 | 106,845 | 124,591 |
| Marketable Securities | 19,434 | 16,583 | 12,520 | 10,221 | 13,945 |
| Receivables | 86,688 | 73,389 | 78,930 | 78,610 | 68,611 |
| Inventories | 98,733 | 95,147 | 92,807 | 100,240 | 97,931 |
| TOTAL | $377,145 | $364,415 | $318,119 | $303,671 | $310,973 |
| Non-Current Assets | |||||
| PPE Net | 237,564 | 243,248 | 244,244 | 242,924 | 252,590 |
| Investments And Advances | 3,065 | 3,318 | 3,985 | 4,193 | 0 |
| Other Non-Current Assets | 105,945 | 105,257 | 105,181 | 100,889 | 102,182 |
| TOTAL | $346,574 | $351,823 | $353,410 | $348,006 | $354,772 |
| Total Assets | $723,719 | $716,238 | $671,529 | $651,677 | $665,745 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,057 | 2,159 | 2,202 | 2,256 | 8,077 |
| Accounts payable and accrued liabilities | 97,665 | 95,810 | 89,545 | 88,911 | 109,604 |
| TOTAL | $103,634 | $114,364 | $103,810 | $97,989 | $124,549 |
| Non-Current Liabilities | |||||
| Long Term Debt | 73,871 | 74,348 | 74,776 | 75,552 | 30,460 |
| Other Non-Current Liabilities | 46,543 | 47,514 | 46,887 | 43,647 | 41,893 |
| TOTAL | $120,778 | $122,349 | $122,197 | $123,512 | $73,973 |
| Total Liabilities | $224,412 | $236,713 | $226,007 | $221,501 | $198,522 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 49,015 | 48,830 | 48,147 | 47,849 | 48,032 |
| Common Shares | 6 | 6 | 6 | 6 | 6 |
| Retained earnings | 221,936 | 204,590 | 180,337 | 160,577 | 130,581 |
| Other shareholders' equity | -8,677 | -7,525 | -7,244 | -6,324 | 40,335 |
| TOTAL | $499,307 | $479,525 | $445,522 | $430,176 | $467,223 |
| Total Liabilities And Equity | $723,719 | $716,238 | $671,529 | $651,677 | $665,745 |